Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-12-15

Clinical Trial Update: Direct Measurement of Proinsulin Clearance in Humans [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating direct measurement of proinsulin clearance in healthy individuals has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Healthy | Phase 4 | Status: WITHDRAWN